Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 14
2018 8
2019 13
2020 9
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.
Ziemssen T, Bass AD, Berkovich R, Comi G, Eichau S, Hobart J, Hunter SF, LaGanke C, Limmroth V, Pelletier D, Pozzilli C, Schippling S, Sousa L, Traboulsee A, Uitdehaag BMJ, Van Wijmeersch B, Choudhry Z, Daizadeh N, Singer BA; CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators. Ziemssen T, et al. CNS Drugs. 2020 Sep;34(9):973-988. doi: 10.1007/s40263-020-00749-x. CNS Drugs. 2020. PMID: 32710396 Free PMC article. Clinical Trial.
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.
Admiraal R, Jol-van der Zijde CM, Furtado Silva JM, Knibbe CAJ, Lankester AC, Boelens JJ, Hale G, Etuk A, Wilson M, Adams S, Veys P, van Kesteren C, Bredius RGM. Admiraal R, et al. Clin Pharmacokinet. 2019 Dec;58(12):1609-1620. doi: 10.1007/s40262-019-00782-0. Clin Pharmacokinet. 2019. PMID: 31131436 Free PMC article.
Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
Bernard F, Uppungunduri CRS, Meyer S, Cummins M, Patrick K, James B, Skinner R, Tewari S, Carpenter B, Wynn R, Veys P, Amrolia P; UK Paediatric BMT group. Bernard F, et al. Br J Haematol. 2021 May;193(4):804-813. doi: 10.1111/bjh.17418. Epub 2021 Apr 14. Br J Haematol. 2021. PMID: 33855694 Clinical Trial.
A prospective pilot study of a novel alemtuzumab target concentration intervention strategy.
Arnold DE, Emoto C, Fukuda T, Dong M, Vinks AA, Lane A, McIntosh K, Neumeier L, Lankester AC, Achini F, Teusink-Cross A, Chandra S, Jordan MB, Nelson AS, Myers KC, Davies SM, Mehta PA, Marsh RA. Arnold DE, et al. Bone Marrow Transplant. 2021 Dec;56(12):3029-3031. doi: 10.1038/s41409-021-01460-1. Epub 2021 Sep 21. Bone Marrow Transplant. 2021. PMID: 34548626
40 results